Centrient
Sustainable leader in antibiotics, statins and anti-fungals
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
First established in 1869, our story has since been one of constant evolution and innovation. Today, we are a company 2,700-people strong with operations on four continents.
More than this, we are a pharmaceutical company with a clear mission: to improve lives by being at the centre of sustainable and accessible healthcare.
Our company has a common focus that unites each of us in our mission: across our global operations, we are committed to ensuring Quality, Reliability and Sustainability to customers, partners, patients and the world at large.
Moving forward, our vision is to be the leading, diversified and fully integrated partner to generics marketers.
Latest news
Planet B.io is a busy community, we are constantly developing and so are our collaborators, residents and members. To keep everyone updated we write articles and organise events. Take a look!
Join Planet B.io at Bio Innovations Europe 2026 – Exclusive 25% discount
We’re happy to be part of the Dutch Biotech Cluster at Bio Innovations Europe 2026, alongside Biotech Booster and hollandbio! Taking place in The Hague on 10-11 June and focused on driving the commercialisation of industrial biomanufacturing in Europe, Bio Innovations Europe will connect over 400 bio-pioneers from across the region for two days of pre-arranged, commercially focused 1-2-1 meetings, knowledge exchange and networking.
Horizon: building the next wave of biotech growth at the Biotech Campus Delft
A new development is on the horizon for the Biotech Campus Delft. With the working title Horizon, ASR Dutch Science Park Fund, together with dsm-firmenich and Planet B.io, is taking the next step in further strengthening the campus as a leading European hub where biotech innovation, collaboration, and scale come together.
High-level Government visit highlights Delft's strategic role in future industrial biotech growth
On 11 March, Erwin Nijsse, Director-General at the Ministry of Economic Affairs and Climate, visited Planet B.io. The visit aligns well with the Netherlands’ evolving political and economic direction and therefore he was joined by a broad delegation of colleagues from several ministries.